Pharmaceuticals

This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.

News

January 7, 2015 — Discussions regarding late-breaking cardiovascular clinical trials among leading medical scientists ...

Home January 07, 2015
Home
News

December 30, 2014 — Wearable technologies, possible changes to stenting practices, state legislation on energy drinks ...

Home December 30, 2014
Home
News

December 23, 2014 — The most accessed research studies in the Journal of the American College of Cardiology (JACC) in ...

Home December 23, 2014
Home
News

December 16, 2014 — Alere Inc. has initiated a voluntary correction to inform United States users of the Alere INRatio ...

Home December 16, 2014
Home
News

November 25, 2014 — Between 70 and 80 percent of patients with the connective tissue condition Marfan syndrome have ...

Home November 25, 2014
Home
AHA, warfarin, antiplatelet therapy, atrial fibrillation, anti-clotting, EP lab
Feature

November 16, 2014 — Long-term overtreatment with the anti-clotting drug warfarin, combined with antiplatelet therapy of ...

Home November 24, 2014
Home
DAPT study
Feature
November 18, 2014 — Patients who took dual antiplatelet therapy medications beyond the standard 12 months after coronary ...
Home November 18, 2014
Home
News

November 12, 2014 — The actions — or inaction — of patients should be considered in programs designed to improve care ...

Home November 12, 2014
Home
News

October 20, 2014 – Heart disease and stroke are the leading causes of death and disability among people with Type 2 ...

Home October 20, 2014
Home
News

October 15, 2014 — Novartis Pharmaceuticals Canada Inc. revealed, in the largest heart failure study to date, that its ...

Home October 15, 2014
Home
News

October 14, 2014 — Researchers have discovered a previously unknown cardiac molecule that could provide a key to ...

Home October 14, 2014
Home
News

September 23, 2014 — New analyses and extended follow-up from the BRIGHT study demonstrated that bivalirudin remained ...

Home September 23, 2014
Home
News

September 22, 2014 — According to a new study, patients receiving six months of dual antiplatelet therapy (DAPT) after ...

Home September 22, 2014
Home
Study Blood Thinner Heart Attack Patients
Feature

September 19, 2014 — The largest prospective longitudinal study of acute myocardial infarction (MI) patients offers ...

Home September 19, 2014
Home
Feature

September 19, 2014 — A new study investigating different durations of triple therapy for anticoagulation after drug ...

Home September 19, 2014
Home
Subscribe Now